Incorrect username and/or password, please try again or click to reset.

Class 2 Medicines Recall: Novartis Pharmaceuticals UK Limited, Adakveo 10 mg/ml concentrate for solution for infusion, EL(24)A/06

2024-02-21 10:56:35 (2 month(s) ago)

Summary

Novartis Pharmaceuticals UK Limited is recalling Adakveo 10 mg/ml concentrate for solution for infusion due to the benefit-risk balance of Adakveo no longer being considered favourable by the MHRA.

Read full MHRA article

Respond to this alert